SCHEMBL2959496

SCHEMBL2959496

Cc1cc(Oc2c(F)cc(C(F)(F)F)cc2Cl)nn1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.36
MAP2K4 P45985 1/20 0.34
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CCR1 P32246 1/20 0.32
CCR2 P41597 1/20 0.32
GABRP O00591 3/20 0.32
GABRD O14764 3/20 0.32
GABRA1 P14867 3/20 0.32
GABRB1 P18505 3/20 0.32
GABRG2 P18507 3/20 0.32
GABRB3 P28472 3/20 0.32
GABRA5 P31644 3/20 0.32
GABRA3 P34903 3/20 0.32
GABRA2 P47869 3/20 0.32
GABRB2 P47870 3/20 0.32
GABRA4 P48169 3/20 0.32
GABRE P78334 3/20 0.32
GABRA6 Q16445 3/20 0.32
GABRG1 Q8N1C3 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2957944 0.89 CCR1 (0.37) MEN1KMT2ACCR1CCR2GABRP
SCHEMBL2962285 0.88 MEN1 (0.41) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL13201703 0.87 GABRP (0.34) MEN1KMT2ACCR1CCR2GABRP
SCHEMBL27168510 0.86 GABRP (0.35) MEN1KMT2ACCR1CCR2GABRP
SCHEMBL1531236 0.84 KMT2A (0.34) KMT2ACCR1CCR2GABRPGABRD
SCHEMBL38481 0.81 NPSR1 (0.37) MEN1KMT2ACCR1CCR2GABRP
SCHEMBL13201705 0.79 MAPT (0.37) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL1531087 0.78 MAPT (0.38) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL1531202 0.78 ALDH1A1 (0.35) MEN1KMT2ACCR1CCR2GABRP
SCHEMBL1531154 0.77 LMNA (0.33) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767827-B2 Pyrazole-1-carboxylate derivatives, process for the production thereof and process for the production of pyrazole derivatives KAKEN PHARMACEUTICAL CO., LTD. (JP) 2010-08-03 US disclosed
US-7767827-B2 Pyrazole-1-carboxylate derivatives, process for the production thereof and process for the production of pyrazole derivatives KAKEN PHARMACEUTICAL CO., LTD. (JP) 2010-08-03 US disclosed
US-20090018345-A1 PYRAZOLE-1-CARBOXYLATE DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND PROCESS FOR THE PRODUCTION OF PYRAZOLE DERIVATIVES KAKEN PHARMACEUTICAL CO., LTD. (JP) 2009-01-15 US disclosed
US-20090018345-A1 PYRAZOLE-1-CARBOXYLATE DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND PROCESS FOR THE PRODUCTION OF PYRAZOLE DERIVATIVES KAKEN PHARMACEUTICAL CO., LTD. (JP) 2009-01-15 US disclosed
EP-1884512-A1 PYRAZOLE-1-CARBOXYLIC ESTER DERIVATIVE, METHOD FOR PRODUCING THE SAME AND METHOD FOR PRODUCING PYRAZOLE DERIVATIVE SAGAMI CHEMICAL RESEARCH CENTER (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018345-A1 PYRAZOLE-1-CARBOXYLATE DERIVATIVES, PROCESS FOR THE PRODUCTION THEREOF AND PROCESS FOR THE PRODUCTION OF PYRAZOLE DERIVATIVES WEE1, CYP51A1, CYP4B1 GPR119 1440/4885MAP2K4 3862/4885MEN1 4418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.